Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

29.96

+0.85 (2.92%)

At close: May 29, 2026, 4:00 PM EDT

29.72

-0.24 (-0.80%)

After-hours: May 29, 2026, 7:21 PM EDT

Capricor Therapeutics Market Cap

Capricor Therapeutics has a market cap or net worth of $1.74 billion as of May 29, 2026. Its market cap has increased by 394.88% in one year.

Market Cap

1.74B

Enterprise Value

1.47B

1-Year Change

394.88%

Ranking

#2179

Market Cap Chart

Since May 13, 2008, Capricor Therapeutics's market cap has increased from $130.10M to $1.74B, an increase of 1,233.62%. That is a compound annual growth rate of 15.43%.

Market Cap History

Date	Market Cap	% Change
May 29, 2026	1.74B	31.50%
Dec 31, 2025	1.32B	110.26%
Dec 31, 2024	627.50M	316.67%
Dec 29, 2023	150.60M	54.62%
Dec 30, 2022	97.40M	37.57%
Dec 31, 2021	70.80M	1.00%
Dec 31, 2020	70.10M	1,198.15%
Dec 31, 2019	5.40M	-57.48%
Dec 31, 2018	12.70M	-68.72%
Dec 29, 2017	40.60M	-28.65%
Dec 30, 2016	56.90M	13.80%
Dec 31, 2015	50.00M	13.90%
Dec 31, 2014	43.90M	1,467.86%
Dec 31, 2013	2.80M	27.27%
Dec 31, 2012	2.20M	-89.91%
Dec 30, 2011	21.80M	1.40%
Dec 31, 2010	21.50M	-36.39%
Dec 31, 2009	33.80M	38.52%
Dec 31, 2008	24.40M	-81.25%
May 13, 2008	130.10M	-

View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Syndax Pharmaceuticals	1.75B
AbCellera Biologics	1.75B
Vericel	1.75B
SELLAS Life Sciences Group	1.71B
Taysha Gene Therapies	1.70B
Novavax	1.70B
Generate Biomedicines	1.68B
Palvella Therapeutics	1.66B

Market Cap Rankings